INmune Bio Reports Statistically Significant Treatment Effect on Advanced White Matter MRI Biomarker in Phase 2 MINDFuL Alzheimer's Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/21/2026

1. INTC
2. DSX
3. GNK
4. TTEC
5. DAL
6. AWK
7. SPCX
8. III
9. TEVA
10. FCLI

Go back to INmune Bio Reports Statistically Significant Treatment Effect on Advanced White Matter MRI Biomarker in Phase 2 MINDFuL Alzheimer's Trial
(NASDAQ: INMB) Delayed: 1.45 +0.15 (11.54%)
Previous Close $1.30    52 Week High $ 
Open $1.32    52 Week Low $ 
Day High $1.45    P/E N/A 
Day Low $1.32    EPS $ 
Volume 446,953